Researcher/postdoc position in CAR T cells and bispecific antibodies

at  Oslo universitetssykehus

Researcher/postdoc position in CAR T cells and bispecific antibodies
Institute for Cancer Research, Department of Cancer Immunology
Apply for position
(in new tab)
About the position

RESEARCH DESCRIPTION:

The Kyte Group has developed several tumor-targeting chimeric antigen receptors (CARs) and other constructs for T cell therapy, as well as tumor targeting antibodies The successful applicant will work on a new project called “CAR360”, for development of personalized T cell therapy countering tumor escape in treatment refractory solid cancers. This includes approaches countering immune suppression and the targeting of multiple antigens and tumor subpopulations. The project will make use of proprietary constructs developed in the group. The successful applicant will also work on the development of therapy with bispecific antibodies and antibody-drug conjugates targeting tumor-specific antigens. Most required methods have been established.
Oslo University Hospital is a workplace with great diversity. We believe this is absolutely crucial to solving the tasks required of us. We therefore want this diversity to be reflected among the applicants for our positions and encourage everyone to apply regardless of who you are and what background you have.
Key information
Application deadline:
26.05.2024
Employer:

Please refer the Job description for details